Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Non-Small Cell Lung Cancer.

This important study reveals a critical role of the transcription factor NR2F2 in mouse fetal Leydig cell (FLC) differentiation. With elegantly carried out experiments, the authors provide compelling ...

Patients with liver tumors that meet the following may be candidates: The tumor is less than 4 centimeters in size Have three or fewer tumors The tumor is in a favorable location for treatment Talk to ...